Several results of EX with insulin therapy in obese T2DM patients have been documented where the combination was found to reduce HbA(1)c, body weight, systolic blood pressure, triglycerides and high-sensitivity CRP[53] along with increased insulin sensitivity and protection against high-fat-induced insulin resistance[54]. The gene discussed is INS; the disease is Insulin resistance.